These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19055588)

  • 21. Enhancing communication among data monitoring committees and institutional review boards.
    Taylor HA; Chaisson L; Sugarman J
    Clin Trials; 2008; 5(3):277-82. PubMed ID: 18559418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stopping clinical trials by design.
    Whitehead J
    Nat Rev Drug Discov; 2004 Nov; 3(11):973-7. PubMed ID: 15520819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Data safety and monitoring boards for African clinical trials.
    Lang T; Chilengi R; Noor RA; Ogutu B; Todd JE; Kilama WL; Targett GA
    Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1189-94. PubMed ID: 18644610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases.
    Filippatos GS; de Graeff P; Bax JJ; Borg JJ; Cleland JG; Dargie HJ; Flather M; Ford I; Friede T; Greenberg B; Henon-Goburdhun C; Holcomb R; Horst B; Lekakis J; Mueller-Velten G; Papavassiliou AG; Prasad K; Rosano GM; Severin T; Sherman W; Stough WG; Swedberg K; Tavazzi L; Tousoulis D; Vardas P; Ruschitzka F; Anker SD
    Eur J Heart Fail; 2017 Apr; 19(4):449-456. PubMed ID: 28271595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management and interpretation of data obtained from clinical trials in pain management.
    Theodore BR; Gatchel RJ
    Pain Pract; 2008; 8(6):461-72. PubMed ID: 19000174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A proposed charter for clinical trial data monitoring committees: helping them to do their job well.
    DAMOCLES Study Group, NHS Health Technology Assessment Programme
    Lancet; 2005 Feb 19-25; 365(9460):711-22. PubMed ID: 15721478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changing landscape of data monitoring committees-Perspectives from regulators, members, and sponsors.
    Bhattacharyya A; Gallo P; Crisp A; LaVange L; Molenberghs G; Pétavy F; Seltzer J
    Biom J; 2019 Sep; 61(5):1232-1241. PubMed ID: 30589102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Playing safe and preserving integrity: making the FDA model work.
    Wittes J
    Stat Med; 2004 May; 23(10):1523-5. PubMed ID: 15122731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials.
    Sydes MR; Spiegelhalter DJ; Altman DG; Babiker AB; Parmar MK;
    Clin Trials; 2004 Feb; 1(1):60-79. PubMed ID: 16281463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Monitoring of clinical trials and interim analysis. 2. Statistic methods].
    Boutitie F; Bellissant E; Blanchard J; Boissel JP; Cauquil J; Chauvin F; Derzko G; Ducruet T; Durrleman S; Girre JP
    Therapie; 1992; 47(4):351-5. PubMed ID: 1494800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis.
    Cook D; Sinuff T; Zytaruk N; Rabbat C; Lee A; O'Donnell M; Thabane L; Linkins L; Treleaven D; Patel R; Meade M; Crowther M; Marshall JC; Douketis J;
    J Crit Care; 2009 Jun; 24(2):168-75. PubMed ID: 19327956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer clinical trials: the emergence and development of a new style of practice.
    Keating P; Cambrosio A
    Bull Hist Med; 2007; 81(1):197-223. PubMed ID: 17369668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liability issues for data monitoring committee members.
    DeMets DL; Fleming TR; Rockhold F; Massie B; Merchant T; Meisel A; Mishkin B; Wittes J; Stump D; Califf R
    Clin Trials; 2004; 1(6):525-31. PubMed ID: 16279293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An introductory note to the CHMP guidelines: choice of the non-inferiority margin and data monitoring committees by David Brown, Peter Volkers and Simon Day, Statistics in Medicine 2006; 25:1623-1627.
    Stat Med; 2007 Jan; 26(1):230-3; author reply 234-5. PubMed ID: 16900566
    [No Abstract]   [Full Text] [Related]  

  • 36. Small group processes relevant to data monitoring committees in controlled clinical trials: an overview of reviews.
    Walker AE; McLeer SK;
    Clin Trials; 2004; 1(3):282-96. PubMed ID: 16279254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Living without a data management system.
    Howells K
    IDrugs; 2008 Oct; 11(10):733-7. PubMed ID: 18828073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Data monitoring in randomized controlled trials: surveys of recent practice and policies.
    Clemens F; Elbourne D; Darbyshire J; Pocock S;
    Clin Trials; 2005; 2(1):22-33. PubMed ID: 16279576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing trial integrity by protecting the independence of data monitoring committees in clinical trials.
    Fleming TR; Hennekens CH; Pfeffer MA; DeMets DL
    J Biopharm Stat; 2014; 24(5):968-75. PubMed ID: 24926941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striding forward or getting too big for their boots? The developing role of data monitoring committees in clinical trials.
    Tharmanathan P; Calvert MJ; Freemantle N
    J Clin Pharm Ther; 2006 Apr; 31(2):111-8. PubMed ID: 16635044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.